<DOC>
	<DOCNO>NCT00171418</DOCNO>
	<brief_summary>Study assess effect add tegaserod PPI therapy result clinically meaningful improvement GERD symptoms patient incomplete relief symptom daily PPI therapy alone .</brief_summary>
	<brief_title>Assessment Effects Tegaserod Management Gastroesophageal Reflux Disease ( GERD ) Patients With Incomplete Response Proton Pump Inhibitors ( PPIs ) .</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Tegaserod</mesh_term>
	<criteria>GERD symptom least 6 month PPI therapy least 4 week Incomplete symptom relief daily PPI therapy No erosive disease evidence EGD/no change symptom severity Evidence structural abnormality gastrointestinal tract disease/conditions Previous gastrointestinal surgery may influence esophageal motor function Known primary esophageal motor disorder Inefficient Esophageal Motor Disorder Evidence cathartic colon history laxative use Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>GERD</keyword>
	<keyword>PPI</keyword>
</DOC>